NFKB1 and metabolic dysfunction-associated steatotic liver disease: Lycopene reduces α7 nicotinic acetylcholine receptor expression in the lung and NF-κB and CYP2E1 expression in the liver in a tobacco-carcinogen-induced ferret model of NAFLD, resulting in ameliorative effects on hepatocyte injury [169].